Data / Form D filings / DARA BioSciences, Inc.
DARA BioSciences, Inc.: Form D filings
DARA BioSciences, Inc., a pharmaceuticals company in Raleigh, NC, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on January 31, 2012, reports $1.4 million sold of an offering with no set size to 10 investors.
Find out what DARA BioSciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8601 SIX FORKS ROAD SUITE 160, Raleigh, NC, 27615
- Phone
- (919) 861-0202
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 919745
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2012 | New notice | Indefinite | $1,448,928 | Indefinite | 10 | Jan 17, 2012 | sec.gov |
| Mar 9, 2010 | New notice | $2,000,000 | $1,716,500 | $283,500 | 22 | Feb 26, 2010 | sec.gov |
| Jun 22, 2009 | New notice | $5,000,000 | $1,397,000 | $3,603,000 | 26 | Jun 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David D Drutz | Executive Officer, Director | |
| Steve F Gorlin | Director | |
| Ann A Rosar | Executive Officer | |
| Haywood D Cochrane | Director | |
| Gail F Lieberman | Director | |
| Christopher F Clement | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jan 30, 2012 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DARA BioSciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.